The University of Chicago Medicine Comer Children's Hospital is a leader in the treatment of pediatric rheumatic conditions. We are one of just three sites in Illinois that specializes in pediatric rheumatology and our board-certified experts are uniquely qualified to provide individualized, comprehensive care for patients and their families. Using the latest tools available, we diagnose and treat juvenile arthritis and other diseases of the joints, muscles, bones and connective tissue, including:
- Chronic joint pain and swelling, including juvenile arthritis and reactive arthritis
- Periodic fevers
- Lyme disease
- Lupus and lupus-like rashes
- Muscle weakness with rash or calcinosis (calcium deposits in the skin/muscle)
In addition, the University of Chicago is the only center in Illinois with a pediatric rheumatologist who is specially trained in the use of ultrasound and has a dedicated musculoskeletal ultrasound clinic. Musculoskeletal ultrasound is a safe and effective tool that is used to complement the physical exam and aid in therapeutic intervention. It allows us to “see” inside the joint as well as the surrounding tissues, which can help with diagnosis of joint, ligament, or tendon pathology. In children, musculoskeletal ultrasound can help in the diagnosis and management of arthritis and related conditions. Ultrasound-guided joint injections have been shown to be more accurate than blind injections and are associated with less procedural pain.
Our approach to care is family-oriented, focusing on the needs of our young patients, as well as the concerns of family members and caregivers. At Comer Children's, our goal is to put children on the road to recovery as quickly as possible, so they can enjoy being kids again.
Advancing Patient Care Through Research
Pediatric rheumatologists at Comer Children's are working to advance patient care through medical education and research. In addition to training clinicians, residents and medical students from across the country and around the world, we participate in collaborative research with other institutions through the Childhood Arthritis and Rheumatology Research Alliance (CARRA). A group of more than 400 pediatric rheumatologists and researchers, CARRA focuses on developing new and better treatments for juvenile arthritis, systemic lupus erythematosus, juvenile dermatomyositis, vasculitis, scleroderma, chronic pain and other rheumatic diseases.